AIG
ARLZ

American International Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

American International Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14
Closed – – 3100
2017
Q2 		$0 Buy
+14
New +$20 ﹤0.01% 3220
2016
Q2 		– Sell
-52,229
Closed -$185K – 5152
2016
Q1 		$185K Buy
+52,229
New +$269K ﹤0.01% 2855

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

American International Group's ARLZ Position: Q3 2017 in Review

American International Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2017, closing a stake of 14 shares.

American International Group first reported a position in ARLZ in Q1 2016 and held it in 2 quarters. The position peaked at $185K in Q1 2016. 59 funds tracked by Wall St. Rank hold ARLZ as of Q3 2017.

  • American International Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
  • American International Group sold 14 Aralez Pharmaceuticals Inc. shares in Q3 2017.
  • American International Group first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 2 quarters.
  • American International Group's Aralez Pharmaceuticals Inc. position peaked at $185K in Q1 2016.
  • 59 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2017.

Based on American International Group's 13F filing for Q3 2017, filed 9 Nov 2017.